Literature DB >> 7332532

The expression of hex A and hex B isozymes of hexosaminidase in parental and experimental human fibroblast cells and their components.

M T Bladon.   

Abstract

The expression of the two major isozyme forms of hexosaminidase (EC 3.2.1.30), hexosaminidase A and hexosaminidase B, has been examined. The parental cells and/or cellular components of parental cells are individually fused using inactivated Sendai virus with the aid of a micromanipulator. The progeny cells produced from such hybrids are subjected to a microenzymatic assay which allows measurements at the single cell level. The lysosomal-deficient cells used in this study are Tay-Sachs and Sandhoff fibroblasts, and the normal cells used are WI-38 (fetal lung fibroblasts), amniotic fluid cells (GM 473), and JASD3 (normal human foreskin). The results show that the ratio of cell components which are fused to form the experimental cell affects the percentage of hexosaminidase A expressed in the progeny cells. Furthermore, our results imply the presence of a "factor" in the Sandhoff cell's cytoplasm which, together with the Tay-Sachs nucleus, is necessary for hexosaminidase A expression in the experimental cell's progeny.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7332532     DOI: 10.1007/bf00504261

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  29 in total

1.  Subunit structure of human hexosaminidase verified: interconvertibility of hexosaminidase isozymes.

Authors:  E Beutler; W Kuhl
Journal:  Nature       Date:  1975-11-20       Impact factor: 49.962

2.  Cellular aging studied by the reconstruction of replicating cells from nuclei and cytoplasms isolated from normal human diploid cells.

Authors:  A L Muggleton-Harris; L Hayflick
Journal:  Exp Cell Res       Date:  1976-12       Impact factor: 3.905

3.  Use of microtechniques for the detection of lysosomal enzyme disorders: Tay-Sachs disease, Gm1-gangliosidosis and Fabry disease.

Authors:  M T Bladon; A Milunsky
Journal:  Clin Genet       Date:  1978-12       Impact factor: 4.438

4.  Changes of enzymic activities in human diploid cell line WI-38 at various passages.

Authors:  K M Wang; N R Rose; E A Bartholomew; M Balzer; K Berde; M Foldvary
Journal:  Exp Cell Res       Date:  1970-08       Impact factor: 3.905

5.  Complementation studies with enucleated fibroblasts from different variants of beta-galactosidase deficiency.

Authors:  H A de Wit-Verbeek; A Hoogeveen; H Galjaard
Journal:  Exp Cell Res       Date:  1978-04       Impact factor: 3.905

6.  On the molecular basis of Sandhoff's disease.

Authors:  H H Ropers; U Schwantes
Journal:  Humangenetik       Date:  1973

7.  Microenzymatic assays for lysosomal enzymes in primary amniotic fluid cell cultures.

Authors:  M T Bladon; A Milunsky
Journal:  Clin Chim Acta       Date:  1980-08-19       Impact factor: 3.786

8.  Fusion with enucleated fibroblasts corrects "I-cell" defect.

Authors:  A D'Azzo; A Konings; A Verkerk; J F Jongkind; H Galjaard
Journal:  Exp Cell Res       Date:  1980-06       Impact factor: 3.905

9.  A study of hexosaminadases in interspecific hybrids and in GM2 gangliosidosis with a discussion on their genetic control.

Authors:  N Van Cong; D Weil; R Rebourcet; J Frézal; A M Richard-Mollard
Journal:  Ann Hum Genet       Date:  1975-07       Impact factor: 1.670

10.  Purification and properties of the hexosaminidase A-activating protein from human liver.

Authors:  P Hechtman; D LeBlanc
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

View more
  1 in total

1.  Gene expression analysis in human breast cancer associated blood vessels.

Authors:  Dylan T Jones; Tanguy Lechertier; Richard Mitter; John M J Herbert; Roy Bicknell; J Louise Jones; Ji-Liang Li; Francesca Buffa; Adrian L Harris; Kairbaan Hodivala-Dilke
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.